Form 4: GoodRx Holdings Officer Acquires Restricted Stock Units and Stock Options

Scott Wagner, Interim CEO of GoodRx Holdings, reports acquisition of restricted stock units and stock options.

Summary

• Scott Wagner, Interim Chief Executive Officer of GoodRx Holdings, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On March 16, 2024, Wagner acquired 564,732 restricted stock units (RSUs) and 908,739 stock options.
• The RSUs will vest in approximately equal monthly installments over eight months beginning on May 8, 2024.
• The stock options will also vest in approximately equal monthly installments over eight months beginning on May 8, 2024, and expire on March 16, 2034.
• Wagner indirectly owns 182,900 shares of Class A Common Stock through the Wagner Family Trust.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of equity could be seen as a positive sign of confidence, but it's a routine event.

Positives

• The acquisition of RSUs and stock options aligns Wagner's interests with those of the shareholders.
• The vesting schedule encourages continued employment and performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with company performance.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to incentivize executives.
• Vesting schedules are typical and designed to retain talent and align interests with long-term shareholder value.
• The specific terms of the RSUs and stock options (vesting period, exercise price) would need to be compared to industry benchmarks to assess their competitiveness.

Stakeholder Impact

• The acquisition of equity by the Interim CEO could be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates